Evidence map›Paper›PMID 41155192›Full record

ReviewInternational journal of molecular sciences2025

Therapeutic Promise and Biotechnological Prospects of

Tomasz Kowalczyk, Martyna Muskała, Janusz Piekarski, Maciej Kowalski, Marek Staszewski, Belma Konuklugil, Patricia Rijo, Przemysław Sitarek

Abstract readReview
In one paragraph

Review in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Tomasz KowalczykDepartment of Molecular Biotechnology and Genetics, Faculty of Biology and Environmental Protection, University of Lodz, Banacha 12/16, 90-237 Lodz, Poland.ORCID 0000-0002-4559-5015
Martyna MuskałaStudents Research Group, Department of Medical Biology, Medical University of Lodz, 90-151 Lodz, Poland.
Janusz PiekarskiDepartment of Surgical Oncology, Medical University of Lodz, Pomorska 251, 93-513 Lodz, Poland.
Maciej KowalskiStudents Research Group, Department of Medical Biology, Medical University of Lodz, 90-151 Lodz, Poland.ORCID 0009-0000-8167-7010
Marek StaszewskiDepartment of Synthesis and Technology of Drugs, Medical University of Lodz, Muszynskiego 1, 90-151 Lodz, Poland.ORCID 0000-0003-2783-522X
Belma KonuklugilDepartment of Pharmacognosy, Faculty of Pharmacy, Ankara University, Ankara 06560, Turkey.
Patricia RijoCBIOS-Research Center for Biosciences & Health Technologies, Universidade Lusófona de Humanidades e Tecnologias, 1749-024 Lisbon, Portugal.ORCID 0000-0001-7992-8343
Przemysław SitarekDepartment of Medical Biology, Medical University of Lodz, Muszyńskiego 1, 90-151 Lodz, Poland.ORCID 0000-0001-5495-3550

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Animal toxins contain various bioactive peptides and proteins which have evolved to interact in specific ways. As such, they are a good starting point for developing new drugs and vaccines. This paper examines three natural neurotoxins derived from the black mamba (

Indexed as

NeurotoxinsSnake VenomsAnimalsBiotechnologyHumansNeoplasmsNeurotoxinsSnake Venomsanticancer effectASIC1ablack mambadendrotoxinfasciculinKv1 channelsmambalginneurotoxinsrecombinant toxinsvenom-derived therapeutics

Identifiers

PMID41155192
PMCPMC12564739

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.